TY - JOUR
T1 - Review of Treatment for Central Spinal Neuropathic Pain and Its Effect on Quality of Life
T2 - Implications for Neuromyelitis Optica Spectrum Disorder
AU - Mealy, Maureen A.
AU - Kozachik, Sharon L.
AU - Levy, Michael
N1 - Publisher Copyright:
© 2019 American Society for Pain Management Nursing
PY - 2019/12
Y1 - 2019/12
N2 - Objectives: Neuromyelitis optica spectrum disorder (NMOSD) causes disabling and persistent central neuropathic pain (NP). Because the pain syndrome in NMOSD is severe and often intractable to analgesic treatment, it interferes with quality of life in patients. No interventional trials have been published looking at response to interventions for pain in NMOSD. This is a synthesis of the literature surveying the impact on quality of life of interventions in all mechanisms of central spinal NP. This review has important implications for management of pain in NMOSD. Methods and Data Sources: A systematic database search was conducted using PubMed, Embase, and CINAHL Plus with keywords including “spinal cord,” “quality of life,” and “neuropathic pain” in an attempt to identify original research that targeted spinal NP treatment and used quality of life as an outcome measure. Both pharmacologic and nonpharmacologic treatments were sought out. Results: Twenty-one studies meeting our eligibility criteria were identified and evaluated, 13 using pharmacologic treatments and 8 using nonpharmacologic interventions. Overall, sample sizes were modest, and effects on decreasing pain and/or improving quality of life were suboptimal. Conclusions: This review provides researchers with a foundation from which to start a more thorough and thoughtful investigation into the management of NP in NMOSD and underscores the importance of including quality of life as a clinically meaningful outcome measure.
AB - Objectives: Neuromyelitis optica spectrum disorder (NMOSD) causes disabling and persistent central neuropathic pain (NP). Because the pain syndrome in NMOSD is severe and often intractable to analgesic treatment, it interferes with quality of life in patients. No interventional trials have been published looking at response to interventions for pain in NMOSD. This is a synthesis of the literature surveying the impact on quality of life of interventions in all mechanisms of central spinal NP. This review has important implications for management of pain in NMOSD. Methods and Data Sources: A systematic database search was conducted using PubMed, Embase, and CINAHL Plus with keywords including “spinal cord,” “quality of life,” and “neuropathic pain” in an attempt to identify original research that targeted spinal NP treatment and used quality of life as an outcome measure. Both pharmacologic and nonpharmacologic treatments were sought out. Results: Twenty-one studies meeting our eligibility criteria were identified and evaluated, 13 using pharmacologic treatments and 8 using nonpharmacologic interventions. Overall, sample sizes were modest, and effects on decreasing pain and/or improving quality of life were suboptimal. Conclusions: This review provides researchers with a foundation from which to start a more thorough and thoughtful investigation into the management of NP in NMOSD and underscores the importance of including quality of life as a clinically meaningful outcome measure.
UR - http://www.scopus.com/inward/record.url?scp=85065556742&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065556742&partnerID=8YFLogxK
U2 - 10.1016/j.pmn.2019.03.003
DO - 10.1016/j.pmn.2019.03.003
M3 - Review article
C2 - 31103517
AN - SCOPUS:85065556742
SN - 1524-9042
VL - 20
SP - 580
EP - 591
JO - Pain Management Nursing
JF - Pain Management Nursing
IS - 6
ER -